Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

A therapeutics company developing targeted solutions for dermatology and oncology.
United Kingdom
INC
INCYTE CORP Logo
A biopharmaceutical company developing proprietary therapeutics for unmet medical needs.
United States of America
INCY
Indivior PLC Logo
Pharmaceutical company developing medicines for substance use and mental disorders.
United Kingdom
INDV
Infant Bacterial Therapeutics Logo
Develops microbiome drugs to prevent or treat rare diseases in premature infants.
Sweden
IBT
Inhibikase Therapeutics, Inc. Logo
Develops kinase inhibitors for neurodegenerative and rare cardiopulmonary conditions.
United States of America
IKT
Inhibrx Biosciences, Inc. Logo
A clinical-stage biopharma company developing biologic therapeutics for oncology.
United States of America
INBX
InMed Pharmaceuticals Inc. Logo
Develops cannabinoid-based drugs and manufactures rare cannabinoids for B2B markets.
United States of America
INM
Inmune Bio, Inc. Logo
A clinical-stage biotech reprogramming the immune system to fight cancer and neurodegeneration.
United States of America
INMB
Innate Pharma Logo
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
France
IPH
INNOGENE Co., Ltd. Logo
Develops and distributes anti-aging products for skin regeneration and hair health.
South Korea
344860

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.